X-84106918-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014496.5(RPS6KA6):āc.1234A>Gā(p.Ile412Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,176,075 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 13 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014496.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPS6KA6 | NM_014496.5 | c.1234A>G | p.Ile412Val | missense_variant | 14/22 | ENST00000262752.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPS6KA6 | ENST00000262752.5 | c.1234A>G | p.Ile412Val | missense_variant | 14/22 | 1 | NM_014496.5 | P1 | |
RPS6KA6 | ENST00000620340.4 | c.1234A>G | p.Ile412Val | missense_variant | 14/22 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000447 AC: 5AN: 111844Hom.: 0 Cov.: 23 AF XY: 0.0000588 AC XY: 2AN XY: 34028
GnomAD3 exomes AF: 0.0000420 AC: 7AN: 166693Hom.: 0 AF XY: 0.0000553 AC XY: 3AN XY: 54205
GnomAD4 exome AF: 0.0000179 AC: 19AN: 1064179Hom.: 0 Cov.: 24 AF XY: 0.0000326 AC XY: 11AN XY: 337053
GnomAD4 genome AF: 0.0000447 AC: 5AN: 111896Hom.: 0 Cov.: 23 AF XY: 0.0000587 AC XY: 2AN XY: 34090
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 29, 2024 | The c.1234A>G (p.I412V) alteration is located in exon 14 (coding exon 14) of the RPS6KA6 gene. This alteration results from a A to G substitution at nucleotide position 1234, causing the isoleucine (I) at amino acid position 412 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at